NcXHF

ASSURING QUALITY CANCER SURVIVORSHIP CARE: WE’VE ONLY JUST BEGUN
FIGURE 3. Imaging or Tumor Marker within 12 Months
of Completed Treatment with Curative Intent (111
Practices)
specialists. Figs. 2A and 2B show the improvement over time
during the period 2009 to 2014. A discussion about the infertility
risk before chemotherapy increased from 20% to 35%.
Likewise, fertility options discussed or referred to a specialist
increased from 11% to 24%. These increases over time may
represent a validation of the QOPI process. However, these
rates are overall low and highlight the need for improvement.
Imaging or Tumor Markers within 12 Months of
Completing Treatment
First in 2006 28 and updated in 2013, 28 the ASCO guideline on
breast cancer follow-up care states that imaging studies or
tumor markers are not recommended in asymptomatic
women with breast cancer who have completed treatment
with curative intent. The percent of medical records that document
imaging or tumor markers within 12 months of completing
treatment with curative intent actually increased
from 25% to 35% over 1 year (Fig. 3). Although there a too
few data points to establish a convincing trend, the fact that
even 25% of medical records document tests that are not ben-
FIGURE 4. (A) Genetic Testing for Invasive Breast Cancer (95 Patients) (B) Complete Family History
Documented for Invasive Breast Cancer (98 Patients)
asco.org/edbook | 2015 ASCO EDUCATIONAL BOOK
e589